My Digital Badge

First Name:
Last Name:
Clinical Speciality:
Select your country

What is your first name?

What is your last name?

What is your clinical speciality?

Regulatory device registrations for the products described in this website are not completed in your country. The products can therefore not be promoted and are not yet available for sale.
Your request for future access is saved!
Your badge is complete!
By clicking ENTER, I agree to GE Healthcare storing my details and contacting me concerning my interests (read more)

Structural Heart

LV hypertrophy seen by ECG, can prompt for further surveillance with echo.

LVH measurement (via ECG) as a predictor of outcome

Left ventricular hypertrophy and “strain” can play a role in the prediction of outcome with regards to the effectiveness of drug intervention to block cardiac remodeling(1,2)
The Marquette™ 12SL program differentiates between ECGs that meet only voltage criteria for left ventricular hypertrophy versus those that meet additional criteria for LVH and/or exhibit other abnormalities that are frequently associated with LVH.(3)


Smart Lead ECG

Helps minimize patient data mix-ups: Automatically detects when a new patient is connected.

Smart Auto-ECG

Reduces repeats: Immediately captures and displays the first clean, high quality waveform.